patients with an abnormal acceleration index ( n = 8 ) showed , compared with non-diabetic ( n = 18 ) controls who had participated in previous studies , an impaired increment in noradrenaline during exercise ( 80 % of maximal working capacity ) ( mwc ) ( 12.38 +/- 1.46 nmol l-1 vs. 18.74 +/- 1.45 nmol l-1 ; p less than 0.01 ) and adrenaline ( 50 % of mwc : 0.25 +/- 0.04 nmol l-1 vs .
C0028351
noradrenaline
C0014563
adrenaline